Halozyme Therapeutics (HALO) Accounts Payables (2010 - 2026)
Halozyme Therapeutics (HALO) reported Accounts Payables of $23.61 million for Q2 2026, up 26.3% from $18.69 million a year earlier and up 67.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Accounts Payables of $20.9 million, up 103.9% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 61.1% (FY2020 to FY2025).
- By year, Accounts Payables came in at $10.25 million in FY2024 (-13.3%), $11.82 million in FY2023 (-33.2%), $17.69 million in FY2022 and $1.54 million in FY2021 (-20.1%).
- The Q2 2026 figure ranks as the highest quarterly Accounts Payables in data going back to Q4 2010.
- Year over year, Accounts Payables gained in five of the last eight quarters, with growth averaging 18.4%.
- The high point for year-over-year Accounts Payables in five years was Q3 2021 (growth of 667.2%); the low point was Q3 2024 (a decline of 35.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.1 million (Q1 2026), $20.9 million (Q4 2025) and $15.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 23.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.61 Mn |
| Mar 31, 2026 | 14.10 Mn |
| Dec 31, 2025 | 20.90 Mn |
| Sep 30, 2025 | 15.36 Mn |
| Jun 30, 2025 | 18.69 Mn |
| Mar 31, 2025 | 20.07 Mn |
| Dec 31, 2024 | 10.25 Mn |
| Sep 30, 2024 | 12.40 Mn |
| Jun 30, 2024 | 15.43 Mn |
| Mar 31, 2024 | 13.33 Mn |
| Dec 31, 2023 | 11.82 Mn |
| Sep 30, 2023 | 19.32 Mn |
| Jun 30, 2023 | 10.12 Mn |
| Mar 31, 2023 | 8.70 Mn |
| Dec 31, 2022 | 17.69 Mn |
| Sep 30, 2022 | 18.17 Mn |
| Jun 30, 2022 | 12.23 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.54 Mn |
| Sep 30, 2021 | 3.32 Mn |
API Access
Halozyme Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();